Coevolution Analysis of HIV-1 Envelope Glycoprotein Complex

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Nov 19

PMID 26579711

Citations 7

Authors

Reda Rawi

Khalid Kunji

Abdelali Haoudi

Halima Bensmail

Affiliations

Soon will be listed here.

Abstract

The HIV-1 Env spike is the main protein complex that facilitates HIV-1 entry into CD4+ host cells. HIV-1 entry is a multistep process that is not yet completely understood. This process involves several protein-protein interactions between HIV-1 Env and a variety of host cell receptors along with many conformational changes within the spike. HIV-1 Env developed due to high mutation rates and plasticity escape strategies from immense immune pressure and entry inhibitors. We applied a coevolution and residue-residue contact detecting method to identify coevolution patterns within HIV-1 Env protein sequences representing all group M subtypes. We identified 424 coevolving residue pairs within HIV-1 Env. The majority of predicted pairs are residue-residue contacts and are proximal in 3D structure. Furthermore, many of the detected pairs have functional implications due to contributions in either CD4 or coreceptor binding, or variable loop, gp120-gp41, and interdomain interactions. This study provides a new dimension of information in HIV research. The identified residue couplings may not only be important in assisting gp120 and gp41 coordinate structure prediction, but also in designing new and effective entry inhibitors that incorporate mutation patterns of HIV-1 Env.

Citing Articles

Selection among site-dependent structurally constrained substitution models of protein evolution by approximate Bayesian computation.

Ferreiro D, Branco C, Arenas M Bioinformatics. 2024; 40(3).

PMID: 38374231 PMC: 10914458. DOI: 10.1093/bioinformatics/btae096.

Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.

Schapiro H, Khasnis M, Ahn K, Karagiaridi A, Hayden S, Cilento M PLoS Pathog. 2022; 18(5):e1010531.

PMID: 35584191 PMC: 9154124. DOI: 10.1371/journal.ppat.1010531.

Analysis of sequence diversity and selection pressure in HIV-1 clade C gp41 from India.

Sutar J, Padwal V, Nagar V, Patil P, Patel V, Bandivdekar A Virusdisease. 2020; 31(3):277-291.

PMID: 32904888 PMC: 7458999. DOI: 10.1007/s13337-020-00595-x.

High affinity CXCR4 inhibitors generated by linking low affinity peptides.

Zhang C, Huang L, Zhu R, Meng Q, Zhu S, Xu Y Eur J Med Chem. 2019; 172:174-185.

PMID: 30978562 PMC: 6677133. DOI: 10.1016/j.ejmech.2019.03.056.

Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.

Curreli F, Belov D, Kwon Y, Ramesh R, Furimsky A, OLoughlin K Eur J Med Chem. 2018; 154:367-391.

PMID: 29860061 PMC: 5993640. DOI: 10.1016/j.ejmech.2018.04.062.

References

Bickel P, Cosman P, Olshen R, Spector P, Rodrigo A, Mullins J . Covariability of V3 loop amino acids. AIDS Res Hum Retroviruses. 1996; 12(15):1401-11. DOI: 10.1089/aid.1996.12.1401. View

Chan D, Fass D, Berger J, Kim P . Core structure of gp41 from the HIV envelope glycoprotein. Cell. 1997; 89(2):263-73. DOI: 10.1016/s0092-8674(00)80205-6. View

Weissenhorn W, Dessen A, Harrison S, Skehel J, Wiley D . Atomic structure of the ectodomain from HIV-1 gp41. Nature. 1997; 387(6631):426-30. DOI: 10.1038/387426a0. View

Tan K, Liu J, Wang J, Shen S, Lu M . Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A. 1997; 94(23):12303-8. PMC: 24915. DOI: 10.1073/pnas.94.23.12303. View

Rizzuto C, Wyatt R, Sun Y, Kwong P, Hendrickson W, Sodroski J . A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 1998; 280(5371):1949-53. DOI: 10.1126/science.280.5371.1949. View

Kwong P, Wyatt R, Robinson J, Sweet R, Sodroski J, Hendrickson W . Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 1998; 393(6686):648-59. PMC: 5629912. DOI: 10.1038/31405. View

Lockless S, Ranganathan R . Evolutionarily conserved pathways of energetic connectivity in protein families. Science. 1999; 286(5438):295-9. DOI: 10.1126/science.286.5438.295. View

Chen B, Vogan E, Gong H, Skehel J, Wiley D, Harrison S . Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein. Structure. 2005; 13(2):197-211. DOI: 10.1016/j.str.2004.12.004. View

Rusert P, Krarup A, Magnus C, Brandenberg O, Weber J, Ehlert A . Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies. J Exp Med. 2011; 208(7):1419-33. PMC: 3135368. DOI: 10.1084/jem.20110196. View

10.

Schnur E, Noah E, Ayzenshtat I, Sargsyan H, Inui T, Ding F . The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide. J Mol Biol. 2011; 410(5):778-97. PMC: 3139148. DOI: 10.1016/j.jmb.2011.04.023. View

11.

Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C . Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science. 2011; 333(6049):1593-602. PMC: 3516815. DOI: 10.1126/science.1207532. View

12.

Pejchal R, Doores K, Walker L, Khayat R, Huang P, Wang S . A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science. 2011; 334(6059):1097-103. PMC: 3280215. DOI: 10.1126/science.1213256. View

13.

Diskin R, Scheid J, Marcovecchio P, West Jr A, Klein F, Gao H . Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science. 2011; 334(6060):1289-93. PMC: 3232316. DOI: 10.1126/science.1213782. View

14.

Morcos F, Pagnani A, Lunt B, Bertolino A, Marks D, Sander C . Direct-coupling analysis of residue coevolution captures native contacts across many protein families. Proc Natl Acad Sci U S A. 2011; 108(49):E1293-301. PMC: 3241805. DOI: 10.1073/pnas.1111471108. View

15.

Liu L, Cimbro R, Lusso P, Berger E . Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A. 2011; 108(50):20148-53. PMC: 3250183. DOI: 10.1073/pnas.1104840108. View

16.

Postler T, Martinez-Navio J, Yuste E, Desrosiers R . Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein. J Virol. 2011; 86(2):1145-57. PMC: 3255797. DOI: 10.1128/JVI.06463-11. View

17.

Jones D, Buchan D, Cozzetto D, Pontil M . PSICOV: precise structural contact prediction using sparse inverse covariance estimation on large multiple sequence alignments. Bioinformatics. 2011; 28(2):184-90. DOI: 10.1093/bioinformatics/btr638. View

18.

Kwon Y, Finzi A, Wu X, Dogo-Isonagie C, Lee L, Moore L . Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl Acad Sci U S A. 2012; 109(15):5663-8. PMC: 3326499. DOI: 10.1073/pnas.1112391109. View

19.

Tran E, Borgnia M, Kuybeda O, Schauder D, Bartesaghi A, Frank G . Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog. 2012; 8(7):e1002797. PMC: 3395603. DOI: 10.1371/journal.ppat.1002797. View

20.

Guttman M, Kahn M, Garcia N, Hu S, Lee K . Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120. J Virol. 2012; 86(16):8750-64. PMC: 3421722. DOI: 10.1128/JVI.07224-11. View